Ariad Pharmaceuticals Inc. (ARIA)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
16-Feb-17 2:16 PM
View: 
Riedel Norbert G
Director
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 139,867----(100%)
139.87K to 0
16-Feb-17 2:17 PM
View: 
Bickerstaff George
Director
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 18,008----(100%)
18.01K to 0
16-Feb-17 2:15 PM
View: 
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 126,352----(100%)
126.35K to 0
16-Feb-17 2:17 PM
View: 
Herron Jennifer Lyn
Exec V.P. Chief Comm'l Officer
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 450----(100%)
0.45K to 0
16-Feb-17 2:15 PM
View: 
Protopapas Anna
Director
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 41,910----(100%)
41.91K to 0
16-Feb-17 2:16 PM
View: 
Cole Hugh M
SVP, Chief Business Officer
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 42,834----(100%)
42.83K to 0
16-Feb-17 2:14 PM
View: 
Denner Alexander J
Director
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 53,173----(< 1%)
12.9M to 12.85M
16-Feb-17 2:15 PM
View: 
Panayiotopoulos Paris
President and CEO
Director
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 159,378----(100%)
159.38K to 0
16-Feb-17 2:18 PM
View: 
Schlesinger Sarah J.
Director
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 55,508----(100%)
55.51K to 0
16-Feb-17 2:14 PM
View: 
Soni Manmeet Singh
EVP, CFO & Treasurer
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 3,273----(100%)
3.27K to 0
16-Feb-17 2:18 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 220,444----(100%)
220.44K to 0
16-Feb-17 2:14 PM
View: 
Denner Alexander J
Director
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 12,850,000----(100%)
12.85M to 0
16-Feb-17 2:17 PM
View: 
Haimovitz Jules
Director
Ariad Pharmaceuticals Inc. (ARIA) 16-Feb-17Disposition 18,008----(100%)
18.01K to 0
16-Feb-17 2:18 PM
View: 
Schlesinger Sarah J.
Director
Ariad Pharmaceuticals Inc. (ARIA) 13-Feb-17Gift 15,600----(22%)
71.11K to 55.51K
02-Feb-17 4:41 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 31-Jan-17Payment of Exercise 9,610$23.82$228,886.00(4%)
229.48K to 219.87K
02-Feb-17 4:42 PM
View: 
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Ariad Pharmaceuticals Inc. (ARIA) 31-Jan-17Option Exercise 29,333----26%
111.69K to 141.02K
02-Feb-17 9:39 AM
View: 
Denner Alexander J
Director
Ariad Pharmaceuticals Inc. (ARIA) 31-Jan-17Grant 18,008----< 1%
12.89M to 12.9M
01-Feb-17 4:56 PM
View: 
Schlesinger Sarah J.
Director
Ariad Pharmaceuticals Inc. (ARIA) 31-Jan-17Grant 18,008----34%
53.1K to 71.11K
02-Feb-17 4:42 PM
View: 
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Ariad Pharmaceuticals Inc. (ARIA) 31-Jan-17Payment of Exercise 14,667$23.81$349,293.00(10%)
141.02K to 126.35K
01-Feb-17 4:55 PM
View: 
Haimovitz Jules
Director
Ariad Pharmaceuticals Inc. (ARIA) 31-Jan-17Grant 18,008----100%
0 to 18.01K
01-Feb-17 4:55 PM
View: 
Riedel Norbert G
Director
Ariad Pharmaceuticals Inc. (ARIA) 31-Jan-17Grant 18,008----15%
121.86K to 139.87K
02-Feb-17 4:41 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 31-Jan-17Option Exercise 29,333----15%
200.14K to 229.48K
01-Feb-17 4:56 PM
View: 
Bickerstaff George
Director
Ariad Pharmaceuticals Inc. (ARIA) 31-Jan-17Grant 18,008----100%
0 to 18.01K
01-Feb-17 4:54 PM
View: 
Protopapas Anna
Director
Ariad Pharmaceuticals Inc. (ARIA) 31-Jan-17Grant 18,008----75%
23.9K to 41.91K
17-Jan-17 5:06 PM
View: 
Panayiotopoulos Paris
President and CEO
Director
Ariad Pharmaceuticals Inc. (ARIA) 17-Jan-17Payment of Exercise 33,300$23.69$788,934.00(17%)
192.68K to 159.38K
(< 1%)
17-Jan-17 5:06 PM
View: 
Panayiotopoulos Paris
President and CEO
Director
Ariad Pharmaceuticals Inc. (ARIA) 13-Jan-17Option Exercise 66,600----53%
126.08K to 192.68K
10-Jan-17 6:17 PM
View: 
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Ariad Pharmaceuticals Inc. (ARIA) 09-Jan-17Market Option Sale (Planned) 32,000$23.78$760,960.00(20%)
161.4K to 129.4K
(< 1%)
10-Jan-17 6:17 PM
View: 
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Ariad Pharmaceuticals Inc. (ARIA) 09-Jan-17Option Exercise 32,000$7.82$250,240.0025%
129.4K to 161.4K
25-Oct-16 4:07 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 24-Oct-16Market Sale (Planned) 19,638$9.56$187,739.00(9%)
217.52K to 197.88K
(149%)
05-Oct-16 4:17 PM
View: 
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Ariad Pharmaceuticals Inc. (ARIA) 03-Oct-16Market Sale (Planned) 47,384$13.46$637,812.00(27%)
176.79K to 129.4K
(77%)
28-Sep-16 4:19 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 28-Sep-16Market Option Sale 8,750$13.98$122,311.00(4%)
226.27K to 217.52K
(70%)
28-Sep-16 4:20 PM
View: 
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Ariad Pharmaceuticals Inc. (ARIA) 26-Sep-16Option Exercise 10,000----6%
166.79K to 176.79K
28-Sep-16 4:19 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 26-Sep-16Option Exercise 17,500----8%
208.77K to 226.27K
23-Sep-16 5:46 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 22-Sep-16Market Sale (Planned) 20,000$13.43$268,536.00(9%)
228.77K to 208.77K
(77%)
16-Sep-16 5:08 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 15-Sep-16Option Exercise 59,369$7.82$464,266.0026%
228.77K to 288.14K
16-Sep-16 5:08 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 15-Sep-16Market Option Sale (Planned) 59,369$11.73$696,398.00(21%)
288.14K to 228.77K
(103%)
23-Aug-16 4:12 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 22-Aug-16Market Sale (Planned) 19,436$10.47$203,538.00(8%)
248.21K to 228.77K
(127%)
15-Aug-16 4:16 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 12-Aug-16Market Option Sale (Planned) 25,000$10.50$262,500.00(9%)
273.21K to 248.21K
(127%)
15-Aug-16 4:16 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 12-Aug-16Option Exercise 25,000$7.69$192,250.0010%
248.21K to 273.21K
25-Jul-16 4:39 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 22-Jul-16Market Sale (Planned) 18,286$8.11$148,230.00(7%)
266.49K to 248.21K
(194%)
14-Jul-16 4:23 PM
View: 
Panayiotopoulos Paris
President and CEO
Director
Ariad Pharmaceuticals Inc. (ARIA) 13-Jul-16Option Exercise 66,600----76%
88.09K to 154.69K
14-Jul-16 4:23 PM
View: 
Panayiotopoulos Paris
President and CEO
Director
Ariad Pharmaceuticals Inc. (ARIA) 13-Jul-16Payment of Exercise 28,611$7.14$204,283.00(18%)
154.69K to 126.08K
(233%)
05-Jul-16 4:07 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 01-Jul-16Option Exercise 61,422$3.88$238,585.0023%
266.49K to 327.92K
05-Jul-16 4:07 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 01-Jul-16Market Option Sale (Planned) 61,422$7.48$459,634.00(19%)
327.92K to 266.49K
(218%)
29-Jun-16 4:25 PM
View: 
Cole Hugh M
SVP, Chief Business Officer
Ariad Pharmaceuticals Inc. (ARIA) 28-Jun-16Market Option Sale 6,012$7.05$42,384.60(17%)
35.93K to 29.92K
(238%)
29-Jun-16 4:25 PM
View: 
Cole Hugh M
SVP, Chief Business Officer
Ariad Pharmaceuticals Inc. (ARIA) 27-Jun-16Option Exercise 19,166----114%
16.76K to 35.93K
23-Jun-16 4:11 PM
View: 
Clackson Timothy P
President, R&D, CSO
Ariad Pharmaceuticals Inc. (ARIA) 22-Jun-16Market Sale 23,999$7.28$174,638.00(8%)
288.74K to 264.74K
(227%)
15-Jun-16 4:19 PM
View: 
Lavidas Athanese
Director
Ariad Pharmaceuticals Inc. (ARIA) 15-Jun-16Option Exercise 46,250$6.55$302,788.0035%
131.63K to 177.88K
15-Jun-16 4:19 PM
View: 
Lavidas Athanese
Director
Ariad Pharmaceuticals Inc. (ARIA) 15-Jun-16Market Option Sale 46,250$8.24$381,137.00(26%)
177.88K to 131.63K
(189%)
15-Jun-16 4:19 PM
View: 
Lavidas Athanese
Director
Ariad Pharmaceuticals Inc. (ARIA) 14-Jun-16Market Option Sale 20,000$8.14$162,852.00(13%)
151.63K to 131.63K
(192%)